BIOLASE, Inc. (BIOL)

$5.28

+0.12 (+2.33%)
Rating:
Recommendation:
Buy
Symbol BIOL
Price $5.28
Beta 1.559
Volume Avg. 0.04M
Market Cap 32.609M
Shares () -
52 Week Range 3.3-23.5
1y Target Est -
DCF Unlevered BIOL DCF ->
DCF Levered BIOL LDCF ->
ROE -51.32% Strong Sell
ROA -27.93% Sell
Operating Margin -
Debt / Equity 143.89% Buy
P/E -
P/B 1.58 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest BIOL news


Mr. Todd Norbe
Healthcare
Medical Devices
NASDAQ Capital Market

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.